Engineers Gate Manager’s RAPT Therapeutics RAPT Stock Holding History

Engineers Gate Manager’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,784	Closed	-$331K	–	2499
2025 Q4	$331K	Buy	+9,784	New	+$304K	﹤0.01%	1580
2025 Q1	–	Sell	-2,079	Closed	-$26.3K	–	2497
2024 Q4	$26.3K	Buy	+2,079	New	+$26.4K	﹤0.01%	2144

Engineers Gate Manager's RAPT Position: Q1 2026 in Review

Engineers Gate Manager sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 9,784 shares — an estimated $331K sold.

Engineers Gate Manager first reported a position in RAPT in Q4 2024 and held it in 2 quarters. The position peaked at $331K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Engineers Gate Manager reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Engineers Gate Manager sold 9,784 RAPT Therapeutics shares in Q1 2026, an estimated $331K.
Engineers Gate Manager first reported a position in RAPT Therapeutics in Q4 2024 and held it in 2 quarters.
Engineers Gate Manager's RAPT Therapeutics position peaked at $331K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.